Device Cos. Slam FDA's Overseas Clinical Trial Rule

A U.S. Food and Drug Administration proposal to strengthen oversight of overseas clinical trials involving medical devices ignores barriers presented by other countries' laws and applies stricter rules than exist on...

Already a subscriber? Click here to view full article